NASDAQ
No price data available for this timeframe.
Foghorn Therapeutics Inc. (FHTX) has a free cash flow growth of -13.45% as of Friday, May 29, 2026. This represents a 725.44% decrease compared to its 12-month average of 2.15%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.